Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Wegovy Maker Novo Nordisk Appoints Jamey Millar Head of Its US Business

Published by Global Banking & Finance Review®

Posted on February 3, 2026

1 min read

Last updated: February 3, 2026

Add as preferred source on Google

Wegovy maker Novo Nordisk appoints Jamey Millar head of its US business - Finance news and analysis from Global Banking & Finance Review

Tags:Appointment management financial community corporate governance

Quick Summary

Novo Nordisk appoints Jamey Millar as US business head and Hong Chow for product strategy, marking key leadership changes.

Wegovy maker Novo Nordisk appoints Jamey Millar head of its US business

Leadership Changes at Novo Nordisk

PARIS, Feb 3 (Reuters) - Danish drug maker Novo Nordisk said on Wednesday it had appointed Jamey Millar head of its U.S. business, and Hong Chow head of product and portfolio strategy.

New Appointments

The maker of weight-loss drug Wegovy said in a statement that Millar would take on the job on February 5, succeeding Dave Moore, and that Hong would start on February 15, replacing Ludovic Helfgott.

Background of New Leaders

Before joining Novo Nordisk, Jamey worked for UnitedHealth Group, as CEO of Optum Specialty Holdings, while Hong joins Novo Nordisk from Merck Healthcare in Germany, it said.

(Reporting by Louise Rasmussen, editing by Anna Ringstrom)

Key Takeaways

•Jamey Millar appointed head of Novo Nordisk's US business.
•Hong Chow to lead product and portfolio strategy.
•Millar succeeds Dave Moore starting February 5.
•Hong Chow joins from Merck Healthcare in Germany.
•Leadership changes to enhance strategic direction.

Frequently Asked Questions about Wegovy maker Novo Nordisk appoints Jamey Millar head of its US business

1What is corporate governance?

Corporate governance refers to the systems and processes that direct and control a company. It involves the relationships among the stakeholders and the goals for which the corporation is governed.

2What is management in a corporate context?

Management in a corporate context involves planning, organizing, leading, and controlling an organization's resources to achieve specific goals efficiently and effectively.

3What is an appointment in a business setting?

An appointment in a business setting refers to the act of assigning a person to a specific position or role within an organization, often involving a formal announcement.

Leadership Changes at Novo Nordisk

PARIS, Feb 3 (Reuters) - Danish drug maker Novo Nordisk said on Wednesday it had appointed Jamey Millar head of its U.S. business, and Hong Chow head of product and portfolio strategy.

New Appointments

The maker of weight-loss drug Wegovy said in a statement that Millar would take on the job on February 5, succeeding Dave Moore, and that Hong would start on February 15, replacing Ludovic Helfgott.

Background of New Leaders

Before joining Novo Nordisk, Jamey worked for UnitedHealth Group, as CEO of Optum Specialty Holdings, while Hong joins Novo Nordisk from Merck Healthcare in Germany, it said.

(Reporting by Louise Rasmussen, editing by Anna Ringstrom)

Frequently Asked Questions

1What is corporate governance?

Corporate governance refers to the systems and processes that direct and control a company. It involves the relationships among the stakeholders and the goals for which the corporation is governed.

2What is management in a corporate context?

Management in a corporate context involves planning, organizing, leading, and controlling an organization's resources to achieve specific goals efficiently and effectively.

3What is an appointment in a business setting?

An appointment in a business setting refers to the act of assigning a person to a specific position or role within an organization, often involving a formal announcement.